Anthem Biosciences Limited

NSE: ANTHEM · Healthcare

Overview

Anthem Biosciences Limited Share Price & Analysis

₹791.55 0.00%Updated 21 Jul 2026, 05:01 pm IST
LTP
₹791.55
+0%
Open
₹—
High
₹804.9
Low
₹784.15
Close
₹791.55
52W High
₹874
52W Low
₹579
Volume
648K
Lot Size
1
Sector
Healthcare
Market Cap
₹44K Cr
Face Value
₹2
Large CapNIFTY 500

Price Chart

Fundamentals

P/E
72
Sector P/E
54.4
P/B
13.94
EPS
₹10.41
ROE
22.3%
ROCE
30.4%
D/E Ratio
0.02
Div Yield
0.26%
Book Value
₹54.2
+

Strengths

  • ✓Excellent return on equity (ROE 22.3%)
  • ✓Efficient capital deployment (ROCE 30.4%)
  • ✓Virtually debt-free
−

Concerns

  • ✗High premium to book value (P/B 13.9x)

Peer Comparison

CompanyCMPMkt CapP/EP/BROE %ROCE %D/E
SUNPHARMA
Sun Pharmaceutical Industries Limited
₹1,944
₹4.6L Cr37.35.591620.50.07
DIVISLAB
Divi's Laboratories Limited
₹7,388
₹1.9L Cr73.411.7116.5220.01
TORNTPHARM
Torrent Pharmaceuticals Limited
₹5,040
₹1.6L Cr73.620.3227.415.20.33
APOLLOHOSP
Apollo Hospitals Enterprise Limited
₹8,939
₹1.3L Cr64.913.5622.117.90.88
CIPLA
Cipla Limited
₹1,416
₹1.1L Cr30.13.3211.615.50.01
ZYDUSLIFE
Zydus Lifesciences Limited
₹1,123
₹1.1L Cr214.1721.221.10.38
LUPIN
Lupin Limited
₹2,405
₹1.1L Cr19.64.928.729.90.32

Showing 7 peers in the same sector · Sorted by market cap

Shareholding Pattern

ANTHEM · as of Jun 2026

Promoters71.42%▼3.25
FII2.57%▲1.29
DII13.48%▲1.93
Public12.52%▲0.04
CategorySep 2025Dec 2025Mar 2026Jun 2026
Promoters74.69%74.69%74.67%71.42%
FII1.66%1.37%1.28%2.57%
DII7.21%7.60%11.55%13.48%
Public16.42%16.34%12.48%12.52%

Corporate Events

To consider and approve the financial results for the period ended Jun 30, 2026

Results20 Jul 2026

Dividend - Rs 2 Per Share

Record: 25 Jun 2026

Dividend24 Jun 2026

Latest News

All news →

Anthem Biosciences receives credit rating update

*Anthem Biosciences receives credit rating update.* The company's latest credit assessment has been filed with the exchange. **No financial figures or rating specifics** were disclosed in the headline. This routine corporate filing may be monitored for future borrowing cost implications. 📊 *STOCKS:* ANTHEM | 🏢 *SECTOR:* Pharma | #LOWIMPACT #CreditRating

NSE Filing3 Jul
High Impact

Anthem Biosciences shares may see low trading interest

*Anthem Biosciences shares may see low trading interest* as the update pertains only to the annual report filing. The disclosure is routine, made under Regulation 36(1)(b) of LODR. No financial or operational updates were provided. Volume and price movement are expected to remain unaffected. 📊 *STOCKS:* ANTHEM | 🏢 *SECTOR:* Pharma | #LOWIMPACT #RegulatoryFiling

NSE Filing8 Jul
Low Impact

Anthem Biosciences announces 20th AGM date

Anthem Biosciences has issued a pre-dispatch intimation for its 20th Annual General Meeting. The notice was published as part of regulatory requirements. No financial figures or strategic updates were disclosed. Shareholders are advised to review the notice for meeting details. 📊 *STOCKS:* ANTHEM | 🏢 *SECTOR:* Pharma | #LOWIMPACT #AGM

NSE Filing29 Jun
Low Impact

Financials

Quarterly Results

MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
Revenue
₹611 Cr
▲44.4%
₹423 Cr
▼23.1%
₹550 Cr
▲1.9%
₹540 Cr
▲11.8%
₹483 Cr
▼3.0%
₹498 Cr
▼5.1%
₹525 Cr
▲54.9%
₹339 Cr
Op. Profit
₹267 Cr
▲70.1%
₹157 Cr
▼28.0%
₹218 Cr
▲14.1%
₹191 Cr
▼2.1%
₹195 Cr
▲21.9%
₹160 Cr
▼17.9%
₹195 Cr
▲61.2%
₹121 Cr
OPM
44.0%
▲18.9%
37.0%
▼7.5%
40.0%
▲14.3%
35.0%
▼12.5%
40.0%
▲25.0%
32.0%
▼13.5%
37.0%
▲2.8%
36.0%
Net Profit
₹190 Cr
▲104.3%
₹93 Cr
▼46.2%
₹173 Cr
▲27.2%
₹136 Cr
▲63.9%
₹83 Cr
▼33.1%
₹124 Cr
▼23.5%
₹162 Cr
▲97.6%
₹82 Cr
EPS (₹)
3.38
▲104.8%
1.65
▼46.6%
3.09
▲27.7%
2.42
▲63.5%
1.48
▼33.3%
2.22
▼23.4%
2.9
▲97.3%
1.47

Values in ₹ Cr · Source: Screener.in

Annual Profit & Loss

MetricMar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020
Revenue
₹2.1K Cr
▲15.1%
₹1.8K Cr
▲30.0%
₹1.4K Cr
▲34.2%
₹1.1K Cr
▼14.1%
₹1.2K Cr
▲11.6%
₹1.1K Cr
▲74.2%
₹633 Cr
Expenses
₹1.3K Cr
▲10.0%
₹1.2K Cr
▲28.3%
₹914 Cr
▲46.0%
₹626 Cr
▼6.0%
₹666 Cr
▼4.2%
₹695 Cr
▲54.1%
₹451 Cr
Op. Profit
₹834 Cr
▲24.1%
₹672 Cr
▲32.8%
₹506 Cr
▲17.4%
₹431 Cr
▼23.7%
₹565 Cr
▲38.5%
₹408 Cr
▲124.2%
₹182 Cr
OPM
39.0%
▲8.3%
36.0%
▲0.0%
36.0%
▼12.2%
41.0%
▼10.9%
46.0%
▲24.3%
37.0%
▲27.6%
29.0%
Other Income
₹131 Cr
▲54.1%
₹85 Cr
▲34.9%
₹63 Cr
▼54.7%
₹139 Cr
▲183.7%
₹49 Cr
▲32.4%
₹37 Cr
▲76.2%
₹21 Cr
Interest
₹7 Cr
▼36.4%
₹11 Cr
▲10.0%
₹10 Cr
▲11.1%
₹9 Cr
▼10.0%
₹10 Cr
▼41.2%
₹17 Cr
▼15.0%
₹20 Cr
Depreciation
₹134 Cr
▲50.6%
₹89 Cr
▲8.5%
₹82 Cr
▲28.1%
₹64 Cr
▲10.3%
₹58 Cr
▼6.5%
₹62 Cr
▲0.0%
₹62 Cr
PBT
₹824 Cr
▲25.4%
₹657 Cr
▲37.7%
₹477 Cr
▼4.0%
₹497 Cr
▼9.0%
₹546 Cr
▲49.2%
₹366 Cr
▲202.5%
₹121 Cr
Tax %
28.0%
▼9.7%
31.0%
▲34.8%
23.0%
▲0.0%
23.0%
▼11.5%
26.0%
▲0.0%
26.0%
▲13.0%
23.0%
Net Profit
₹592 Cr
▲31.3%
₹451 Cr
▲22.9%
₹367 Cr
▼4.7%
₹385 Cr
▼5.2%
₹406 Cr
▲49.8%
₹271 Cr
▲191.4%
₹93 Cr
EPS (₹)
10.54
▲30.6%
8.07
▲22.8%
6.57
▼2.7%
6.75
▼98.5%
462.09
▲44.5%
319.74
▲189.0%
110.62
Div Payout
19.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%

Values in ₹ Cr · Source: Screener.in

Balance Sheet

ItemMar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020
Liabilities
Equity Capital
₹112 Cr
▲0.0%
₹112 Cr
▲0.0%
₹112 Cr
▼1.8%
₹114 Cr
▲1166.7%
₹9 Cr
▲12.5%
₹8 Cr
▲0.0%
₹8 Cr
Reserves
₹2.9K Cr
▲27.5%
₹2.3K Cr
▲26.8%
₹1.8K Cr
▲11.4%
₹1.6K Cr
▲20.9%
₹1.3K Cr
▲94.2%
₹693 Cr
▲67.8%
₹413 Cr
Borrowings
₹54 Cr
▼52.2%
₹113 Cr
▼52.7%
₹239 Cr
▲89.7%
₹126 Cr
▲260.0%
₹35 Cr
▼65.0%
₹100 Cr
▼37.1%
₹159 Cr
Other Liabilities
₹333 Cr
▲17.3%
₹284 Cr
▲20.9%
₹235 Cr
▲58.8%
₹148 Cr
▼35.1%
₹228 Cr
▼1.7%
₹232 Cr
▲12.1%
₹207 Cr
Total Liabilities
₹3.4K Cr
▲22.1%
₹2.8K Cr
▲17.1%
₹2.4K Cr
▲19.1%
₹2.0K Cr
▲24.4%
₹1.6K Cr
▲56.6%
₹1.0K Cr
▲31.4%
₹787 Cr
Assets
Fixed Assets
₹783 Cr
▲11.1%
₹705 Cr
▲46.0%
₹483 Cr
▲7.6%
₹449 Cr
▲36.5%
₹329 Cr
▼8.9%
₹361 Cr
▲18.0%
₹306 Cr
CWIP
₹264 Cr
▼11.1%
₹297 Cr
▼13.9%
₹345 Cr
▲110.4%
₹164 Cr
▲6.5%
₹154 Cr
▲710.5%
₹19 Cr
▼62.0%
₹50 Cr
Investments
₹1.0K Cr
▲132.6%
₹433 Cr
▼8.3%
₹472 Cr
▼5.4%
₹499 Cr
▲82.8%
₹273 Cr
▲30.6%
₹209 Cr
▲111.1%
₹99 Cr
Other Assets
₹1.4K Cr
▲0.1%
₹1.4K Cr
▲24.9%
₹1.1K Cr
▲21.8%
₹902 Cr
▲4.5%
₹863 Cr
▲93.9%
₹445 Cr
▲33.6%
₹333 Cr
Total Assets
₹3.4K Cr
▲22.1%
₹2.8K Cr
▲17.1%
₹2.4K Cr
▲19.1%
₹2.0K Cr
▲24.4%
₹1.6K Cr
▲56.6%
₹1.0K Cr
▲31.4%
₹787 Cr

Values in ₹ Cr · Source: Screener.in

Cash Flow Statement

ItemMar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020
Operating CF
₹844 Cr
▲211.4%
₹271 Cr
▲93.6%
₹140 Cr
▼54.2%
₹306 Cr
▼8.1%
₹333 Cr
▲19.8%
₹278 Cr
▲67.5%
₹166 Cr
Investing CF
₹-702 Cr
▼377.6%
₹-147 Cr
▲33.5%
₹-221 Cr
▲41.2%
₹-376 Cr
▼83.4%
₹-205 Cr
▼4.6%
₹-196 Cr
▼79.8%
₹-109 Cr
Financing CF
₹-40 Cr
▲70.6%
₹-136 Cr
▼76.6%
₹-77 Cr
▼220.3%
₹64 Cr
▼64.6%
₹181 Cr
▲387.3%
₹-63 Cr
▼31.3%
₹-48 Cr
Net Cash Flow
₹103 Cr
▲958.3%
₹-12 Cr
▲92.4%
₹-158 Cr
▼2533.3%
₹-6 Cr
▼101.9%
₹308 Cr
▲1611.1%
₹18 Cr
▲100.0%
₹9 Cr
Free Cash Flow
₹637 Cr
▲5208.3%
₹12 Cr
▲107.7%
₹-156 Cr
▼239.3%
₹112 Cr
▼63.5%
₹307 Cr
▲93.1%
₹159 Cr
▲33.6%
₹119 Cr

Values in ₹ Cr · Source: Screener.in

Key Ratios History

MetricMar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020
Debtor Days
101d
▲13.5%
89d
▼29.4%
126d
▲32.6%
95d
▼2.1%
97d
▲15.5%
84d
▲37.7%
61d
Inventory Days
56d
▼66.5%
167d
▲29.5%
129d
▼7.2%
139d
▲167.3%
52d
▲79.3%
29d
▼84.4%
186d
Days Payable
34d
▼37.0%
54d
▼11.5%
61d
▼20.8%
77d
▲54.0%
50d
▲0.0%
50d
▼42.5%
87d
Cash Conv. Cycle
124d
▼38.6%
202d
▲4.7%
193d
▲23.7%
156d
▲57.6%
99d
▲57.1%
63d
▼60.6%
160d
Working Capital Days
92d
▼31.3%
134d
▲4.7%
128d
▲14.3%
112d
▲49.3%
75d
▲177.8%
27d
▲35.0%
20d
ROCE
30.0%
▲7.1%
28.0%
▲16.7%
24.0%
▼14.3%
28.0%
▼45.1%
51.0%
▼7.3%
55.0%
—

Source: Screener.in · Lower days = better efficiency

About Anthem Biosciences Limited

Incorporated in 2006, Anthem Biosciences Ltd is in the business of providing CRDMO services and the manufacture and sale of specialty ingredients.[1]

Healthcare · Pharmaceuticals & Biotechnology

Related Analysis

Same Sector

ALKEM
Alkem Laboratories Limited
Neutral
APOLLOHOSP
Apollo Hospitals Enterprise Limited
Neutral
AUROPHARMA
Aurobindo Pharma Limited
Neutral
BIOCON
Biocon Limited
Neutral
CIPLA
Cipla Limited
Neutral

Frequently Asked Questions

What is Anthem Biosciences Limited share price today?▾
Anthem Biosciences Limited (ANTHEM) is currently trading at ₹791.55 on NSE, up 0.00% as of the last market session. Prices update daily after market close on MarketNetra.
Is Anthem Biosciences Limited available in F&O (Futures & Options)?▾
Yes, Anthem Biosciences Limited (ANTHEM) is part of the NSE F&O segment with a lot size of 1 shares. Options are available with monthly expiry contracts. You can track the full option chain and OI analysis on MarketNetra.
What is Anthem Biosciences Limited 52-week high and low?▾
Anthem Biosciences Limited's 52-week high is ₹874 and the 52-week low is ₹579. The current price of ₹791.55 is 9.4% below the 52W high.
What is Anthem Biosciences Limited P/E ratio?▾
Anthem Biosciences Limited's current P/E ratio is 72. This indicates the market is paying ₹72 for every ₹1 of earnings. Compare this to the sector average to assess relative valuation.
How to trade Anthem Biosciences Limited options?▾
Anthem Biosciences Limited options are traded on NSE with monthly expiry contracts (lot size: 1 shares). To trade ANTHEM options: select your expiry on the option chain page, identify key OI strikes, check the PCR and buildup type on OI analysis, and review FII/DII flows for institutional sentiment before taking a position.